info@upjac.com  | +1 (347) 486-4833

United Conference of Women Leaders in Pharma

Theme : Working Together to Achieve Success and Enhance Female Progress in the Pharmaceutical Industry

Webinar on Women Leaders in Pharma | July 14-15, 2021

Exhibitors
Sponsorships
Conferences 2022

About The Conference

On behalf of United Conferences, we are overwhelmed to welcome all the interested participants to attend “United Conference of Women Leaders in Pharma” Webinar on July 14-15, 2021. This conference boats of a huge variety of Keynote presentations, plenary talks, Poster presentations and Career development programs.

United Conference of Women Leaders in Pharma aims to bring together a significant number of leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Research and Development on Pharmaceutical Industry It is a foremost integrative platform for researchers, educators and practitioners alike to present and explore the latest innovations, trends, and concerns as well as practical challenges encountered and solutions adopted during this pandemic.

Previous Keynotes

Amanda DeMarzo

Associate Director, Patient Access New Jersey, United States

Zina Kobbi
Zina Kobbi

CEO of AREMA, Nabeul Governorate, Tunisia

Orlaith Ryan
Orlaith Ryan

Chief Technical Officer Shorla Pharma, Ireland

Marieke Meulemans
Marieke Meulemans

CEO GCP Central B.V.,Amsterdam, North Holland, Netherlands

Eden Lord

Founder & CEO at My City Med, Founder of The Civitas Foundation, USA

Danielle Drachmann

Executive Director at Ketotic Hypoglycemia International, Committee member at the European Health Parliament, Patient Representative at the European Medicines Agency, Rare2030 EURORDIS, Europe

Nashwa Nashaat

CEO & Co-Founder Nexus eHealth Formal regional Medical Director for J&J and Eli Lilly Novartis: Pharmacovigilance Lead

Liana Kasyan
Liana Kasyan

Founder/CEO and Principal PV Consultant at ETL Pharmacovigilance Center Ltd. Armenia

Julia Appelskog

EU QPPV, Head of QPPVs & Safety Consulting. Pharmacovigilance Director, Sweden

Penelope Przekop

Chief Compliance Officer at Engrail Therapeutics | CEO at PDC Pharma Strategy, USA

Shereen Agwa
Shereen Agwa

Country Safety Team Lead for South Africa and Sub Saharan Africa, Egypt

Dr. Preeti Patel
Dr. Preeti Patel

Drug Safety Associate, Sollers, United States

Dr. Dina Avery

Assistant Professor & Associate Scientist - University of Alabama at Birmingham, USA

Veronika Valdova
Veronika Valdova

Ilana Frishman
Ilana Frishman

Safety Director at Pluristem Therapeutics, Israel

Ongoing Keynotes

Huma Qamar
Huma Qamar MD, MPH

Senior Vice President, Head of R&D Program, FSD Pharma, Inc. USA

Hetal Shah
Dr Hetal Shah

Pharmaceuticals & CROs - Independent Consultant & Founder-Director - MeWriT Healthcare Consulting, India

Gail Trauco
Gail Trauco

Advisory Committee Member COVID-19 FDA, Principal CEO The PharmaKon LLC, USA

Dr Lia Hunter
Dr Lia Hunter

Director Clinnovate Ltd, south Croydon, England, United Kingdom

Galyna Malygina
Galyna Malygina

Senior Project Manager, LLC OtiPharm® Data Pro

Rebecca Centko
Rebecca Centko

Director of Project Management & Account Management, Regis Technologies, USA

Speakers

Virtual Exhibitors

GCP-Central-Logo_white
GCP Central
ASTE Logo

ASTE Pharmaceuticals, Medical & Laboratory Supplies

TGMP Consulting

Informed DNA
Informed DNA
Diamond Pharmaceuticals

Webinar Registration Charges

  • Keynote/ Speaker Registration 199 USD
  • Speaker Registration 149 USD
  • Delegate Registration 99 USD
  • Student Delegate Registration 50 USD
  • Poster Presentation Registration 50 USD
  • Video Presentation Registration 50 USD
  • E-Banner Registration 50 USD

Who Can Attend

  • Managers, Directors, and VPs.
  • Pharmaceutical companies.
  • Hospitals, healthcare system & healthcare providers.
  • Health insurance companies.
  • Biotech companies
  • Medical device manufacturers.
  • Healthcare-related associations and foundations.
  • Industry influencers (solutions providers, educational organizations, government entities and venture capitalists).

Why Choose Us

  • Global & Local Expertise
  • Prospective Attendees
  • Larger worldview of the profession
  • We’re passionate about what we do
  • We focus on your career growth
  • Transparency in Communication
  • Open gateway towards INNOVATION
  • Strong sense of identification
  • Quality without compromise
  • Highly organised and structured scientific programs

Key Takeaways

  • Professional Worldwide
  • International Recognition of Researchers
  • Knowledge into Asset
  • Cognizance of leading Cutting – Edge technologies
  • Publication of Abstracts in preeminent supported journals
  • New Accomplishments with Edu – tech ideas
  • Exposure to the upcoming business trends
  • Free access to our forthcoming International events
  • Certificate of presentation with International signatories

United Pharma Technologies Collaborations and Associations

Marieke Meulemans
Marieke Meulemans
CEO GCP Central B.V., Amsterdam, North Holland, Netherlands
Biography: She is a Founder and CEO of GCP Central since 2012 with over 15 years of experience within the clinical research world, and is the driving force behind the company vision.

Expertise:
•Development of practice-based and effective online GCP training for clinical research professionals.
•Setup and implementation of Learning Management Systems.

Specialties: eLearning development ; online GCP training; training needs analysis; process improvement; training management; blended learning; Good Clinical Practice; Clinical research rules & regulations; Wet Medisch Wetenschappelijk Onderzoek (WMO) training
Biography: Executive director at Ketotic Hypoglycemia International. Her work started with the establishment of an international patient association where they are in close collaboration with national and international researchers, have written scientific papers and conducted research projects using a Citizen Science approach. Most recently, she entered the European Health Parliament and the European Medicines Agency as a Patient Representative for patients with rare hypoglycemia diseases. Furthermore, she have been working for EURORDIS (European Organization for Rare Diseases) to develop recommendations for Europes' rare disease policy in the Rare2030 project.
Nashwa Nashaat
CEO & Co-Founder Nexus eHealth Formal regional Medical Director for J&J and Eli Lilly Novartis: Pharmacovigilance Lead
Biography: She has dedicated her career to improving the patients’ care and healthcare services. Inspired by the advancement in technology and her personal mission to serve patients, she has co-founded a company where the unmet patient’s needs drive the innovation for personalized technology-based solutions. In her role as a Chief Executive Officer and Co-founder for Nexus eHealth, she is committed to being a catalyst in the adoption of precision medicine through the Technology Enabled Connected Care solutions and building the healthcare technology capabilities, especially in the Middle East and Africa.
Prior to founding Nexus eHealth, being a physician; with PhD in Pediatric Oncology/Hematology, she devoted her passion to improve cancer patients’ lives and affordability of medicine by working with different global medical societies, NGOs and policy makers for more than 18 years. She has also worked for top multinational pharmaceutical, diagnostics and medical devices companies (Novartis, Eli Lilly and Johnson & Johnson) during the last 11 years where she took several global executive leadership roles in R&D, GxP auditing, medical affairs, patients advocacy and support programs, governmental affairs, business development, market access, healthcare policies and digital transformation strategies.

She was honored with 25 global awards for innovation, excellence and patient centricity. She authored more than 20 scientific publications. She serves as technical advisor and organizational leadership coach qualified by Glasgow university. She has been volunteering in different community services in Africa and a member in the Global Camper of Commerce and Industry (GCCI) that support the spirit of entrepreneurship. She is an Egyptian woman who constantly advocates the promotion of equality, diversity and inclusion & woman empowerment across the corporate world and the society as a whole.
Liana Kasyan
Liana Kasyan
Founder/CEO and Principal PV Consultant at ETL Pharmacovigilance Center Ltd. Armenia
Biography: Founder/CEO and Principal PV Consultant at the ETL Pharmacovigilance Center Ltd., - Pharmacovigilance Instructor at the Open Education Office of the American University of Armenia, - Member of International Society of Pharmacovigilance (ISoP), - International Editorial Board Member for the Journal of Pharmacovigilance and Drug Research (JPADR), - Reviewer of Master Тheses at the Faculty of Public Health of Yerevan State Medical University, - Board Member of Armenian Association of Specialists in Evidence-Based Medicine (AASEBM), - Co-founder of “Do not Harm’’ Health NGO.
Huma Qamar
Huma Qamar
Senior Vice President, Head of R&D Program, FSD Pharma, Inc. USA
Biography: Huma Qamar is a Health care professional with more than 16 years of work experience in clinical medicine, surgery, pharmaceutical, Health Law, Oncology Research, patient centered outcomes research, Phase 1 trials, Women's Health, Sarcoma, Melanoma, Hematology, CART-19,Clinical Operations, Medicare Coverage Analysis, Prospective Reimbursement Analysis, Medical Affairs, Vendor Management, Good Clinical Practice (GCP), ICH, Fetal and Pediatric research, IND/IDE, Project planning, CRO, Medical Devices, Clinical Protocols, Flexible Schedule, Calibration,health outcomes research, public health, clinical research, regulatory affairs in research development, organizational delivery, Pharmacovigilance, mental health counseling, research project management, program planning and evaluation, clinical trial budgets and contracts, billing and compliance, epidemiology, electronic data capture (EDC), statistics, health marketing, information technology and business development in multiple therapeutic areas.Excellent leadership, management, interpersonal, presentation and communication skills. High degree of emotional intelligence with ability to connect with people and build strong cross-functional relationships, internally and externally.
Hetal Shah
Dr. Hetal Shah
Pharmaceuticals & CROs - Independent Consultant & Founder-Director - MeWriT Healthcare Consulting, India
Biography: Dr Hetal Shah, an expert medical writing professional by passion and profession; is currently the Founder - Director of MeWriT Healthcare Consulting.

Dr Shah is a PhD Pharmacologist with over 17 years of first-hand experience in the field of medical writing and clinical research project management. A gold medallist for her manifold academic achievements, she also has several national and international publications to her credit including book chapters, research papers and reviews.
An independent consultant with high standards for quality and work ethics, Dr Shah is extensively involved in developing integral regulatory documentation & publications for pharmaceuticals & research organizations.

As a medical writing expert, she takes full accountability for first-hand writing, editing and finalizing of submission-ready documents for various therapeutic areas. Her writing sphere currently ranges from preparation of clinical trial documents to clinical study reports; compilation of drug authorization dossiers to scientific publications for journals.

She is also an experienced trainer with practical approach to coaching, and independently conducts medical writing workshops customized for various topics and audiences’ needs. She is a member of the executive committee of All India Medical Writers Society (Under formation), member of Indian Society od Clinical Research, and an ex-member of the DIA Medical Writing group of India and ISMPP.

An accomplished professional herself, she effectively collaborates with medical experts, bio-statisticians, in-house and allied teams to ensure a complete, accurate, cost-effective, and timely solution for your medical writing needs, with the best of quality and ethics.
Gail Trauco
Gail Trauco
Advisory Committee Member COVID-19 FDA, Principal CEO The PharmaKon LLC, USA
Biography: The PharmaKon LLC specializes in clinical pharmaceutical product development and trials. It is a 100% woman owned business led by its CEO/founder Gail Trauco, R.N., BSN-OCN. The PharmaKon partners with biopharmaceutical and biotech companies, investigators, site staff, lab and technology vendors, and regulatory authorities to reinforce patient safety and access throughout every phase of research. All play a part in delivering the quality data that can drive promising compounds forward.
For nearly 30 years, The PharmaKon’s dedicated government and public health services group has successfully delivered clinical research services to various agencies, contractors and nonprofits in both prime contractor and subcontractor capacities within full compliance of all federal contracting requirements. Its services have supported the organizations in conducting therapeutic, vaccine and medical device studies on a global scale across all trial phases and therapeutic areas.

The PharmaKon has a unique understanding and connection to rural healthcare and underserved communities by way of Trauco’s personal experiences growing up on a family farm in her native North Carolina. Despite challenges with generational grief and poverty, Trauco persevered through high school and college at University of North Carolina at Chapel Hill and then began a life and career of her own as an oncology nurse. Trauco worked for the Chief of Surgical Oncology at Duke University Cancer Cener, Dr. Hilliard Siegler, a pioneer in the field of immunotherapy in 1957, whom she credits for her foundation of knowledge about medicine.

A registered Oncology nurse, pharmaceutical trials expert, and long-time Patient advocate, Trauco has spent four decades helping patients navigate the sea of red tape in the American healthcare system. Based just outside Atlanta, she has gained a reputation as a fierce advocate for patient’s rights and for resolving some of the most difficult medical cases in the currently crippled healthcare industry. As a lifelong healthcare professional and frequent on camera expert, Gail Trauco is equal parts Gloria Allred, Erin Brokovich, and Nancy Grace…with a small twist of Dog the Bounty Hunter.

For more information about Gail Trauco and The PharmaKonLLC visit:
https://thepharmakonllc.com/
Dr Lia Hunter
Dr Lia Hunter
Director Clinnovate Ltd, South Croydon, England, United Kingdom
Biography: Dr Lia Hunter has over 25 years experience in the Pharmaceutical/ Biopharmaceutical Industry. She has held various positions including Research Chemist, Lecturer, Clinical Trial Administrator, Clinical Research Associate, Clinical Trial Auditor, Clinical Project Manager and Consultant. This expansive experience has developed skills and expertise such that she has overseen the progression of projects from the preclinical phase right through to market authorisation.
In 2015, Lia set up Clinnovate Ltd, a Clinical Research Consultancy, providing expertise to pharmaceutical and biopharmaceutical companies to facilitate clinical project delivery. In this capacity, Lia has successfully delivered trials within the timelines and to budget, whilst ensuring patient safety, data integrity and regulatory compliance is never compromised.

Lia has extensive experience leading key studies on high profile programmes for leading pharmaceutical companies, especially in Oncology, Gastroenterology and Infectious disease. Lia worked on a key programme for her client Takeda Pharmaceuticals in a Global position with oversight of the CRO Strategic Partner and associated Vendors and is Leading Clinical Operations Oversight at Biogen currently.
Galyna Malygina
Galyna Malygina
Senior Project Manager, LLC OtiPharm® Data Pro
Biography: An expert in the implementation and development of projects of various levels. In the IT industry since 2008, has extensive experience in other industries. Speaker of pharmaceutical forums, provide consultation to pharmaceutical companies in choosing IT products for automatisation business processes inside of the company.
Rebecca Centko
Rebecca Centko
Director of Project Management & Account Management, Regis Technologies, USA
Biography: Rebecca Centko is an Excellent communicator with a strong ability to manage business needs while delivering for clients. I have an ability to influence at all levels of the organization. I have a demonstrated history of leading a project management group with a strong understanding of the sales process, business needs, the drug development process, quality aspects, and cGMP manufacturing requirements. I can work within a team to identify and resolve problems quickly.

Submit Manuscript

Manuscript Details

Author Details